Page 118 - Read Online
P. 118

Gutierrez et al. Microbiome Res Rep 2023;2:36                 Microbiome Research
               DOI: 10.20517/mrr.2023.37
                                                                                               Reports




               Review                                                                        Open Access



               Bifidobacterium and the intestinal mucus layer


               Alyssa Gutierrez 1  , Brenton Puckett 1  , Melinda A. Engevik 1,2
               1
                Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC 29425, USA.
               2
                Department of Microbiology & Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
               Correspondence to: Dr. Melinda A. Engevik, Department of Regenerative Medicine and Cell Biology, Medical University of South
               Carolina, 173 Ashley Ave, Basic Science Building 601, Charleston, SC 29425, USA. E-mail: engevik@musc.edu

               How to cite this article: Gutierrez A, Puckett B, Engevik MA. Bifidobacterium and the intestinal mucus layer. Microbiome Res Rep
               2023;2:36. https://dx.doi.org/10.20517/mrr.2023.37

               Received: 21 Jun 2023  First Decision: 7 Aug 2023  Revised: 21 Aug 2023   Accepted: 13 Sep 2023   Published: 27 Sep 2023

               Academic Editor: Francesca Turroni  Copy Editor: Pei-Yun Wang  Production Editor: Pei-Yun Wang

               Abstract
               Bifidobacterium species are integral members of the human gut microbiota and these microbes have significant
               interactions with the intestinal mucus layer. This review delves into Bifidobacterium-mucus dynamics, shedding
               light on the multifaceted nature of this relationship. We cover conserved features of Bifidobacterium-mucus
               interactions, such as mucus adhesion and positive regulation of goblet cell and mucus production, as well as
               species and strain-specific attributes of mucus degradation. For each interface, we explore the molecular
               mechanisms underlying these interactions and their potential implications for human health. Notably, we
               emphasize the ability of Bifidobacterium species to positively influence the mucus layer, shedding light on its
               potential as a mucin-builder and a therapeutic agent for diseases associated with disrupted mucus barriers. By
               elucidating the complex interplay between Bifidobacterium and intestinal mucus, we aim to contribute to a deeper
               understanding of the gut microbiota-host interface and pave the way for novel therapeutic strategies.

               Keywords: Bifidobacterium, mucus, intestine, probiotic



               INTRODUCTION
               Intestinal mucus
               The intestine is continually exposed to a multitude of luminal antigens and bacterial components. To
               protect itself, the intestinal epithelium harbors specialized cells known as goblet cells, which synthesize and
               secrete mucus. The structure of intestinal mucus is intricately designed to form a protective barrier. The






                           © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                        www.oaepublish.com/mrr
   113   114   115   116   117   118   119   120   121   122   123